Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by TheeRookon Feb 14, 2021 3:21am
185 Views
Post# 32563874

RE:RE:Zzzzzzz

RE:RE:ZzzzzzzWith the new CV19 variants spreading around   it looks like SONAs testing will have to be done again to prove it can detect the new  variants.  Since SONAs test test the Spike Protein and the mutated Cv19 viruses changes in the Spike protein it does not look good.


Tests use to detect the variant strains, first emerging in the United Kingdom and in South Africa,  targeting the nucleocapsid protein on the SARS-Cov-2 coronavirus are likely unaffected.   Since the  majority of the mutations appearing to date are of the spike protein.

 Thus researchers continue  to monitor the situation closely and do not anticipate efficacy concerns with the variants that have occurred thus far for tests that target  the N protein..




MikeyH wrote: If any major contracts had been signed SONA would have issued a NR immediately to stem the stock price bleed. Anyone who thinks otherwise is living in cloud cuckoo land.

The lawsuits are interesting, but I agree won't go anywhere. SONA's NRs have been generally crappy and poorly written, but not wholly misleading. Ambulance chasers for sure


<< Previous
Bullboard Posts
Next >>